Skip to content

Patients With Upper Gastrointestinal Bleeding in Emergency Department

Analysis of the Outcome of Patients With Suspected Upper GI Bleeding Managed in Emergency Departments in Ile de France and External Validation of Prognostic Scores

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05927493
Acronym
UGIB-ED
Enrollment
2000
Registered
2023-07-03
Start date
2019-01-01
Completion date
2021-02-01
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Bleeding

Keywords

Upper gastrointestinal bleeding, Emergency department, Low-risk, Scores

Brief summary

More than 80% of patients with upper gastrointestinal bleeding (UGIB) are hospitalized after their visit to the emergency department (ED). However, some of these hospitalizations do not seem justified. Several clinical scores have been developed to classify patients according to their risk of death or need for therapeutic intervention. The aims of this study are: 1. to describe the characteristics of patients hospitalized for UGIB after their visit to the ED 2. to assess the predictive factors of hospital intervention or death 3. to assess the accuracy of existing prognostic scores to classify patients according their risk of death or need for therapeutic intervention (external validation) and to identify low-risk patients not requiring intervention. 4. Depending on the results, a new score could be derived to identify patients at low risk for intervention or death.

Detailed description

Upper gastrointestinal bleeding (UGIB) is caused by several conditions, with an overall mortality of approximately 10%. More than 80% of patients are hospitalized after their visit to the emergency department (ED) \[1\]. The hospitalization usually allows an etiological diagnosis to be made by performing an upper gastrointestinal endoscopy (UGE) and a hemostatic treatment if required. However, some of these hospitalizations do not seem justified. Indeed, some patients do not require any intervention (i.e., blood transfusion, endoscopic, radiological or surgical hemostasis) and have no complications (i.e., rebleeding, death). Some of them do not even have a diagnostic UGE during their hospital stay. Several clinical scores have been developed to classify patients according their risk of death or need for therapeutic intervention, some of them to identify patients with low-risk of complications (rebleeding, death) and/or need for intervention. The most commonly known are the pre-endoscopic Rockall score, the Glasgow-Blatchford Score (GBS) and the AIMS65. Among them, the GBS seems to be the most efficient \[2,3\]. Its use is encouraged in the latest French, European and international recommendations \[4\]. Other prognostic scores have more recently been proposed with this purpose (e.g. modified GBS, CANUKA, H3B2, C-Watch, Harbinger), with interesting results but scarce or no external validation. The aims of this study are: 1. to describe the characteristics of patients hospitalized for UGIB after their visit to the ED 2. to assess the predictive factors of death or therapeutic intervention (i.e, blood transfusion, endoscopic hemostasis, surgery or interventional radiology) 3. to assess the accuracy of existing prognostic scores to classify patients according their risk of death or need for therapeutic intervention (external validation) and to identify low-risk patients not requiring intervention. 4. Depending on the results, a new score could be derived to identify patients at low risk for intervention or death.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patient ≥ 18 years old * with a diagnosis of upper gastrointestinal bleeding (defined by ICD10 codes) * visited a hospital with ED data available in the data warehouse

Exclusion criteria

* reason for consultation not related to upper gastrointestinal bleeding (identified by manual reading of hospital notes)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients treated with specific therapeutic intervention7 daysBlood transfusion or endoscopic hemostasis or radiological hemostasis or surgical hemostasis in 7 days
Number of deceased patients30 days

Secondary

MeasureTime frameDescription
number of patients treated with endoscopic hemostasis7 daysArterioembolization or transjugular intrahepatic portosystemic shunt placement
Number of patients treated with endoscopic hemostasis7 daysAny hemostasis technique used during upper gastrointestinal endoscopy
Death30 daysIntrahospital death
number of patients treated with interventional radiology hemostasis7 daysAny hemostasis technique used during surgery
Number of patients treated with blood transfusion(s)7 daysTransfusion of at least 1 red blood cell unit

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026